The Global Surgical Sutures Market Size is projected to grow at a CAGR of 7.57% during the forecast period from 2026 to 2034 | DelveInsight

DelveInsight's Surgical Sutures Market Insights Report 2034 provides the current and forecast market analysis, individual leading Surgical Sutures Companies market shares, challenges, Surgical Sutures Market Drivers, barriers, trends, and key market Surgical Sutures companies in the market.

To read more about the latest highlights related to the Surgical Sutures Market @ https://www.delveinsight.com/sample-request/surgical-sutures-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Key Takeaways from the Surgical Sutures Market Report
• In December 2025, Teleflex Incorporated announced definitive agreements to divest its Teleflex Medical OEM business, which manufactures surgical fibers and sutures, to Montagu and Kohlberg in a carve-out transaction valued at approximately USD 1.5 billion, alongside a separate USD 530 million sale of its acute care and interventional urology businesses, with closing expected in the second half of 2026. Strategic significance: Reshapes the competitive supplier base for contract-manufactured surgical fibers and sutures and signals continued portfolio realignment among diversified medtech suppliers.
• In 2025 and 2026, Johnson & Johnson (Ethicon) continued to expand its wound closure and surgical portfolio, reinforced by growing clinical endorsement of triclosan-coated antibacterial suture technology by the CDC, WHO, and the American College of Surgeons and Surgical Infection Society as a recommended measure for surgical site infection prevention. Strategic significance: Strengthens Ethicon's antimicrobial suture leadership and reinforces guideline-backed clinical demand for coated wound closure products.
• In 2025, Meril Life Sciences Pvt. Ltd. expanded its MITSU AB triclosan-coated, antibacterial braided synthetic absorbable suture line, broadening its endosurgery wound closure portfolio for global markets. Strategic significance: Extends Meril's antimicrobial and barbed suture offering and strengthens its competitive position across Asia-Pacific and export markets.
• In 2025, DemeTECH Corporation continued expanding its custom suture manufacturing capacity at its Miami Lakes, Florida facility, broadening distribution of its absorbable and non-absorbable suture portfolio to more than 100 countries. Strategic significance: Strengthens DemeTECH's position as a scaled, cost-competitive alternative to multinational suture manufacturers.
• The Surgical Sutures Market is estimated at USD 6.03 billion in 2025 and is projected to reach USD 11.52 billion by 2034. Growth is anchored by the rising global volume of surgical procedures, increasing prevalence of chronic wounds and traumatic injuries, expanding adoption of minimally invasive and robotic-assisted surgeries requiring advanced wound closure solutions, and continuous product innovation, including antimicrobial, absorbable, and barbed sutures, supported by expanding healthcare infrastructure and improving access to surgical care worldwide.
• The Global Surgical Sutures Market is growing at a CAGR of 7.57% during the forecast period from 2026 to 2034.
• The principal drivers are the rising global volume of surgical procedures, with roughly 600,000 knee replacement and 200,000 coronary artery bypass graft procedures performed annually in the United States alone; the growing burden of chronic and cardiovascular disease, responsible for 17.9 million deaths globally in 2019 per the WHO; an expanding geriatric population; continuous technological advancement in antimicrobial and barbed suture technology; and the growth of minimally invasive surgery and ambulatory surgical centers.
• North America dominated the surgical sutures market with a 39% share of global revenue in 2025, supported by high surgical procedure volumes, well-established hospital and ambulatory surgical infrastructure, favorable reimbursement, and the concentrated presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
• The leading Surgical Sutures Companies include Johnson & Johnson (Ethicon), Medtronic PLC, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A. de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, and Lotus Surgicals, and others.

To know more about why North America is leading the market growth in the Surgical Sutures Market, Get a snapshot @ https://www.delveinsight.com/sample-request/surgical-sutures-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Surgical Sutures Overview
Surgical sutures are sterile medical devices used to close wounds, secure tissues, and facilitate healing following surgical procedures or traumatic injuries. They play a critical role in maintaining tissue approximation, minimizing bleeding, reducing the risk of infection, and promoting proper wound healing. Surgical sutures are widely used across various medical specialties, including general surgery, cardiovascular surgery, orthopedic surgery, gynecology, ophthalmology, plastic surgery, and gastrointestinal surgery.

Surgical Sutures Market Key Growth Drivers
• The rising global volume of surgical procedures is driving demand, with roughly 600,000 knee replacements and about 200,000 coronary artery bypass graft procedures performed annually in the United States alone.
• The rising global burden of chronic and cardiovascular disease is expanding demand for surgical intervention, with the WHO attributing 17.9 million deaths in 2019 to cardiovascular disease, the leading cause of surgical referral worldwide.
• An expanding geriatric population is increasing the incidence of hip and knee replacement, hernia repair, and cardiovascular procedures that rely heavily on suture-based wound closure.
• Continuous technological advancement, including antibacterial triclosan-coated sutures now recommended by the CDC, WHO, and the American College of Surgeons and Surgical Infection Society for reducing surgical site infection, is broadening premium-suture adoption.
• Rapid adoption of barbed, knotless suture technology is reducing operative time and knot-related complications across cosmetic, orthopedic, and gynecological procedures.
• The shift toward minimally invasive and robot-assisted surgery is increasing demand for fine-gauge, high-tensile-strength synthetic sutures engineered for small-incision handling.
• The expansion of ambulatory surgical centers and outpatient procedure volumes, particularly across the United States, China, and India, is broadening the distributed demand base for Surgical Sutures.
• The convergence of rising surgical volumes, an aging population, minimally invasive adoption, and antimicrobial and barbed suture innovation is expected to sustain steady growth in the market through 2034.

Get a sneak peek at the Tele Surgical Sutures Market Dynamics @ https://www.delveinsight.com/sample-request/surgical-sutures-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Surgical Sutures Market Segment Analysis
The Surgical Sutures Product Type (Suturing Devices, Suture Threads [Absorbable and Non-Absorbable]), Suture Type (Natural and Synthetic), Suture Filament (Monofilament, Multifilament, and Barbed), Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Ophthalmic Surgery, Gynecological Surgery, and Others), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Surgical Sutures Market Competitive Landscape
The Surgical Sutures market is classified as Moderately Consolidated. Johnson & Johnson, along with Medtronic, B. Braun Melsungen AG, Smith & Nephew, and Boston Scientific, anchor the top tier through broad product portfolios, global manufacturing scale, and deep hospital distribution relationships, while specialized and fast-scaling manufacturers such as DemeTECH Corporation, Meril Life Sciences, Teleflex Incorporated, Internacional Farmacéutica, and Lotus Surgicals compete through cost efficiency, regional manufacturing depth, and targeted product innovation, increasing competition across both developed and emerging markets.

Which MedTech key players in the Surgical Sutures Market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/sample-request/surgical-sutures-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Surgical Sutures Companies
Johnson & Johnson (Ethicon), Medtronic PLC, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A. de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, and Lotus Surgicals, and others.

Surgical Sutures Market Restraints
Despite steady momentum, the Surgical Sutures market faces material constraints. The global shift toward alternative wound closure technologies, including surgical staples, tissue adhesives, and mechanical closure devices, is displacing sutures in select applications where speed and ease of use are prioritized over the tensile strength and versatility of thread-based closure. Pricing pressure from a highly fragmented base of regional and low-cost manufacturers, particularly across India, Turkey, and China, is compressing margins for global brands. Stringent regulatory requirements for medical device approval, sterilization validation, and biocompatibility testing lengthen product development timelines and raise costs, particularly for antimicrobial and bioresorbable innovations. The high cost of antimicrobial and barbed sutures relative to conventional products limits accessibility in price-sensitive healthcare systems, while reimbursement structures in several emerging markets remain uneven.

Interested in knowing the Surgical Sutures Market by 2034? Click to get a snapshot of the Surgical Sutures Market Trends- https://www.delveinsight.com/sample-request/surgical-sutures-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Scope of the Surgical Sutures Market Report
• Coverage- Global
• Forecast Period- 2025-2034
• Surgical Sutures Companies- Johnson & Johnson (Ethicon), Medtronic PLC, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A. de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, and Lotus Surgicals, and others.
• Surgical Sutures Market Restraints and Regulatory Analysis
• Surgical Sutures Porter Five Forces Analysis
• Surgical Sutures Market Assessment

Explore more information of the Surgical Sutures Market Insights @ https://www.delveinsight.com/sample-request/surgical-sutures-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Table of Contents
1. Surgical Sutures Market Report Introduction
2. Surgical Sutures Market Executive Summary
3. Surgical Sutures Competitive Landscape
4. Surgical Sutures Regulatory Analysis
5. Surgical Sutures Market Key Factors Analysis
6. Surgical Sutures Market Porter's Five Forces Analysis
7. Surgical Sutures Market Assessment
8. Surgical Sutures Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.